Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Amount Raised
$7 Million
Round Type
Seed
San DiegoBiotechnologyHealthcareDescription
Primmune Therapeutics today announced that it has raised $7 million in seed financing to support the development of novel orally-administered, small molecule toll-like receptor 7 (TLR7) agonists for long-term systemic activation of innate immunity. Investors in the seed financing were CAM Capital, Charlie McDermott, BioBrit, and BioRock Ventures.
Quick answer
Primmune Therapeutics raised $7 Million in a Seed round, dated March 2, 2020. Primmune Therapeutics is based in San Diego, California, United States.
- How much did Primmune Therapeutics raise?
- Primmune Therapeutics raised $7 Million in a Seed round on March 2, 2020.
- What does Primmune Therapeutics do?
- Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy.
- Where is Primmune Therapeutics based and how big is it?
- Primmune Therapeutics is based in San Diego, California, United States. Fundz records about 10 employees.
- Who are the decision-makers at Primmune Therapeutics?
- Fundz holds 1 contact at Primmune Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Primmune Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- OnKure Therapeutics raised $3.2M (Seed) on April 15, 2020.
- Phio Pharmaceuticals raised $4.4M on April 14, 2020.
- Crispr Therapeutics raised $1M (Seed) on April 9, 2020.
- Eton Pharmaceuticals raised $7.5M on April 8, 2020.
- Monogram Health raised $7M on April 8, 2020.
- Diasome Pharmaceuticals raised $2.9M (Seed) on April 1, 2020.
Who to call at Primmune Therapeutics, and when
A new round usually means Primmune Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Primmune Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Primmune Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Primmune Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Primmune Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Primmune Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.